| 2026-05-25 | Mr. Peter Neil SmithExecutive Chairman & MD | 16,20k | 867,26 | Kauf | 0,05 | 73,37M | 0,02% |
| 2026-05-20 | Mr. Peter Neil SmithExecutive Chairman & MD | 15,80k | 871,23 | Kauf | 0,06 | 73,35M | 0,02% |
| 2026-05-14 | Mr. Peter Neil SmithExecutive Chairman & MD | 19,00k | 1,06k | Kauf | 0,06 | 73,34M | 0,03% |
| 2026-05-06 | Mr. Peter Neil SmithExecutive Chairman & MD | 30,00k | 1,63k | Kauf | 0,05 | 73,32M | 0,04% |
| 2026-05-04 | Mr. Peter Neil SmithExecutive Chairman & MD | 19,00k | 1,06k | Kauf | 0,06 | 73,29M | 0,03% |
| 2026-04-20 | Mr. Peter Neil SmithExecutive Chairman & MD | 12,00k | 688,56 | Kauf | 0,06 | 73,27M | 0,02% |
| 2026-04-17 | Mr. Michael Jarvis PoveyCFO, Company Secretary & Executive Director | -19,00k | 1,11k | Verkauf | 0,06 | 15,22M | -0,12% |
| 2026-04-17 | Mr. Peter Neil SmithExecutive Chairman & MD | 12,00k | 698,71 | Kauf | 0,06 | 73,26M | 0,02% |
| 2026-04-16 | Mr. Peter Neil SmithExecutive Chairman & MD | 16,59k | 939,18 | Kauf | 0,06 | 73,25M | 0,02% |
| 2026-01-05 | Mr. Peter Neil SmithExecutive Chairman & MD | 13,33k | 671,44 | Kauf | 0,05 | 73,23M | 0,02% |
| 2025-12-30 | Mr. Peter Neil SmithExecutive Chairman & MD | 51,00k | 2,46k | Kauf | 0,05 | 73,22M | 0,07% |
| 2025-11-26 | Mr. Peter Neil SmithExecutive Chairman & MD | 25,00k | 1,22k | Kauf | 0,05 | 72,16M | 0,03% |
| 2025-09-23 | Mr. Peter Neil SmithExecutive Chairman & MD | 40,00k | 1,45k | Kauf | 0,04 | 72,14M | 0,06% |
| 2025-09-17 | Mr. Peter Neil SmithExecutive Chairman & MD | 107,00k | 3,56k | Kauf | 0,03 | 72,10M | 0,15% |
| 2025-09-11 | Mr. Peter Neil SmithExecutive Chairman & MD | 22,00k | 746,55 | Kauf | 0,03 | 71,99M | 0,03% |
| 2025-09-10 | Mr. Peter Neil SmithExecutive Chairman & MD | 103,04k | 3,32k | Kauf | 0,03 | 38,08M | 0,27% |
| 2025-09-04 | Mr. Peter Neil SmithExecutive Chairman & MD | 41,97k | 1,29k | Kauf | 0,03 | 37,97M | 0,11% |
| 2025-09-02 | Mr. Peter Neil SmithExecutive Chairman & MD | 57,00k | 1,71k | Kauf | 0,03 | 71,83M | 0,08% |
| 2025-09-01 | Mr. Peter Neil SmithExecutive Chairman & MD | 86,36k | 2,49k | Kauf | 0,03 | 71,77M | 0,12% |
| 2025-08-28 | Mr. Peter Neil SmithExecutive Chairman & MD | 119,00k | 3,38k | Kauf | 0,03 | 71,68M | 0,17% |
| 2025-08-19 | Mr. Peter Neil SmithExecutive Chairman & MD | 35,00k | 1,13k | Kauf | 0,03 | 71,56M | 0,05% |
| 2025-07-23 | Mr. Peter Neil SmithExecutive Chairman & MD | 2,78M | 89,71k | Kauf | 0,03 | 71,53M | 4,04% |
| 2025-07-23 | Mr. Michael Jarvis PoveyCFO, Company Secretary & Executive Director | 1,31M | 0,00 | Derivative Exercise and Retained Stock | - | 15,24M | 9,43% |
| 2025-07-23 | Mr. Peter Neil SmithExecutive Chairman & MD | -2,78M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-23 | Mr. Michael Jarvis PoveyCFO, Company Secretary & Executive Director | -1,46M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-06-26 | Mr. Peter Neil SmithExecutive Chairman & MD | 54,00k | 1,73k | Kauf | 0,03 | 68,75M | 0,08% |
| 2025-06-23 | Mr. Peter Neil SmithExecutive Chairman & MD | 20,00k | 630,86 | Kauf | 0,03 | 68,69M | 0,03% |
| 2025-06-10 | Mr. Peter Neil SmithExecutive Chairman & MD | 12,00k | 430,21 | Kauf | 0,04 | 68,67M | 0,02% |